Mesco Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Mesco Pharmaceuticals Stock Forecast and Price Target
If the average 2024 price target of 4.56 recently set by prominent experts for Mesco Pharmaceuticals is met, there would be a potential upside of approximately 5.31% from the last closing price in October, 2021. The high estimate is 5.11, and the low is 4.06. If you are not interested in 500274 stock, you may be interested in its competitors.
5.31% Upside
Mesco Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Mesco Pharmaceuticals's Price has grown, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach 4.29 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.53k | Buy/Sell | Rp1.52k | 3.65% |
| CIPLA Stock Forecast | Cipla | Outperform |
18
|
Rp1.42k | Buy/Sell | Rp1.43k | 5.28% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.30k | Buy/Sell | Rp5.67k | -3.98% |
| ZYDUSLIFE Stock Forecast | Zydus Lifesciences | Outperform |
18
|
Rp1.02k | Buy/Sell | Rp655.25 | -15.01% |
| 500420 Stock Forecast | Torrent Pharmaceuticals | Outperform |
18
|
Rp2.72k | Buy/Sell | Rp2.13k | 3.11% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500257 Stock Forecast | Lupin | Hold |
12
|
Rp1.68k | Buy/Sell | Rp1.11k | -7.72% |
| AUROPHARMA Stock Forecast | Aurobindo Pharma | Outperform |
18
|
Rp1.16k | Buy/Sell | Rp1.09k | 1.10% |
| 500488 Stock Forecast | Abbott India | Outperform |
18
|
Rp25.76k | Buy/Sell | Rp24.75k | 14.51% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500660 Stock Forecast | GlaxoSmithKline Pharmaceutical... | Hold |
18
|
Rp2.08k | Buy/Sell | Rp1.78k | 1.54% |
| IPCALAB Stock Forecast | Ipca Laboratories | Hold |
18
|
Rp1.34k | Buy/Sell | Rp987.00 | -14.20% |
| GLENMARK Stock Forecast | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.04k | Buy/Sell | Rp767.80 | -13.08% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 506943 Stock Forecast | J. B. Chemicals & Pharmaceutic... | Outperform |
18
|
Rp1.85k | Buy/Sell | Rp1.89k | 4.90% |
| AJANTPHARM Stock Forecast | Ajanta Pharma | Outperform |
18
|
Rp2.41k | Buy/Sell | Rp1.95k | 5.82% |
| 500302 Stock Forecast | Piramal Enterprises | Hold |
18
|
Rp951.55 | Buy/Sell | Rp1.11k | 5.09% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APLLTD Stock Forecast | Alembic Pharmaceuticals | Hold |
16
|
Rp1.02k | Buy/Sell | Rp742.44 | -10.65% |
| PFIZER Stock Forecast | Pfizer | Outperform |
18
|
Rp4.27k | Buy/Sell | Rp4.53k | 15.56% |
| 500674 Stock Forecast | Sanofi India | Outperform |
18
|
Rp8.54k | Buy/Sell | Rp8.61k | 7.42% |
Mesco Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last year, Mesco Pharmaceuticals's EBIT has decreased by 95.92%, going from -980.00k to -40.00k. In the next year, analysts predict that EBIT will jump to -980.00k – up 2350.00% from the current level. Looking ahead to nine years, experts forecast that EBIT will grow by 291024.76%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NATCOPHARM Stock Forecast | NATCO Pharma | Outperform |
16
|
Rp1.02k | Buy/Sell | Rp822.45 | -1.09% |
| 506820 Stock Forecast | AstraZeneca Pharma India | - |
18
|
Rp5.41k | Buy/Sell | Rp0.00 | -100.00% |
| 524742 Stock Forecast | Caplin Point Laboratories | Buy |
17
|
Rp1.31k | Buy/Sell | Rp1.47k | 17.70% |
Mesco Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Mesco Pharmaceuticals's EPS has grown, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.00 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 532482 Stock Forecast | Granules India | Buy |
18
|
Rp422.35 | Buy/Sell | Rp381.00 | 13.65% |
| STAR Stock Forecast | Strides Pharma Science | Outperform |
9
|
Rp883.00 | Buy/Sell | Rp618.00 | -6.74% |
| 500126 Stock Forecast | Procter & Gamble Health | - |
17
|
Rp4.70k | Buy/Sell | Rp5.62k | -100.00% |
Site Navigation
.jpg)